[{"address1": "2223 Avenida de la Playa", "address2": "Suite 208", "city": "LA Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "619 400 1170", "website": "https://www.gribio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.", "fullTimeEmployees": 1, "companyOfficers": [{"maxAge": 1, "name": "Dr. W. Marc Hertz Ph.D.", "age": 52, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 842014, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leanne M. Kelly", "age": 46, "title": "CFO & Corporate Secretary", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 550930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vipin  Kumar Chaturvedi Ph.D.", "age": 63, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Albert  Agro Ph.d.", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.8067, "open": 0.8153, "dayLow": 0.795, "dayHigh": 0.88, "regularMarketPreviousClose": 0.8067, "regularMarketOpen": 0.8153, "regularMarketDayLow": 0.795, "regularMarketDayHigh": 0.88, "volume": 297498, "regularMarketVolume": 297498, "averageVolume": 707935, "averageVolume10days": 241200, "averageDailyVolume10Day": 241200, "bid": 0.857, "ask": 0.87, "bidSize": 800, "askSize": 1100, "marketCap": 857091, "fiftyTwoWeekLow": 0.751, "fiftyTwoWeekHigh": 115.5, "fiftyDayAverage": 1.61842, "twoHundredDayAverage": 13.72186, "currency": "USD", "enterpriseValue": -3052814, "floatShares": 367144, "sharesOutstanding": 976186, "sharesShort": 18586, "sharesShortPriorMonth": 22202, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.019, "heldPercentInsiders": 0.17749001, "heldPercentInstitutions": 0.04596, "shortRatio": 0.01, "shortPercentOfFloat": 0.021300001, "impliedSharesOutstanding": 976186, "bookValue": 5.273, "priceToBook": 0.16650864, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -13302000, "trailingEps": -31.5, "lastSplitFactor": "1:7", "lastSplitDate": 1706572800, "enterpriseToEbitda": 0.283, "52WeekChange": -0.9891685, "SandP52WeekChange": 0.3288405, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "GRI", "underlyingSymbol": "GRI", "shortName": "GRI Bio, Inc.", "longName": "GRI Bio, Inc.", "firstTradeDateEpochUtc": 1612967400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "2a4b9e2e-4254-393c-ba83-44e16bef237a", "messageBoardId": "finmb_136941170", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.878, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 3488000, "totalCashPerShare": 7.521, "ebitda": -10774000, "totalDebt": 28000, "quickRatio": 1.602, "currentRatio": 2.006, "debtToEquity": 1.257, "returnOnAssets": -2.92499, "freeCashflow": -6234000, "operatingCashflow": -4274000, "financialCurrency": "USD", "trailingPegRatio": null}]